Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.
about
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewNovel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationAdvances on genetic rat models of epilepsy.Mechanisms of Action of Antiseizure Drugs and the Ketogenic DietThe potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategiesWhat you seize is what you get: do we yet understand epilepsy in rett syndrome?Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.Ethosuximide reduces electrographical and behavioral correlates of alcohol withdrawal seizure in DBA/2J mice.Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsyEthosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal.Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial.2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.The challenge and promise of anti-epileptic therapy development in animal models.Past and present definitions of epileptogenesis and its biomarkers.Long-term seizure remission in childhood absence epilepsy: might initial treatment matter?Low threshold T-type calcium channels as targets for novel epilepsy treatments.Anti-epileptogenesis: Electrophysiology, diffusion tensor imaging and behavior in a genetic absence model.Evaluating whole genome sequence data from the Genetic Absence Epilepsy Rat from Strasbourg and its related non-epileptic strain.Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.Advancing pharmacologic treatment options for pharmacologic treatment options for children with epilepsy.The Genetic Absence Epilepsy Rats from Strasbourg model of absence epilepsy exhibits alterations in fear conditioning and latent inhibition consistent with psychiatric comorbidities in humans.Anxiety and locomotion in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): inclusion of Wistar rats as a second control.Seizure expression, behavior, and brain morphology differences in colonies of Genetic Absence Epilepsy Rats from Strasbourg.Integrative properties and transfer function of cortical neurons initiating absence seizures in a rat genetic model.Building Up Absence Seizures in the Somatosensory Cortex: From Network to Cellular Epileptogenic Processes.
P2860
Q26743786-2D68E787-64FC-4780-82F4-29AF36E56CE4Q26823386-A32098D8-9141-471D-96EB-B7457D35AD56Q27024903-3794808E-D879-40E0-86B8-071C8DE61E1CQ28272457-C24B285D-16DE-4A37-9858-D3E11CD723CFQ30576758-3C63B2C5-ED1A-45CB-A52C-27451D798C3DQ30576762-2CBB8DBB-B085-4EA0-92E7-A5CB0AA88B87Q34306205-E351CAFC-399E-464B-A689-012AB6E1ECA6Q34941977-1125E57D-5B78-4329-8648-88940F9EEC70Q35231077-FC165DA3-2B01-441A-9668-AFF8746CF71CQ35693028-248A492F-F6B6-43B8-A646-4DFDB97CDE8DQ35956950-000395D7-F303-4FFB-A679-FE89F2EA04EBQ36156651-045A5AC2-0B8B-4074-BA48-5EEA5D7AE19DQ37021058-1C657365-C56A-42C2-8F3D-33B16D3C03C1Q37214420-55F1C0F3-F7BF-4533-A217-9B2221A1D8C8Q37717423-F02EAEAA-503D-4EAC-91C8-C60FD7CD0317Q37722372-5BB9470D-5ACF-4F20-8FB6-1FE320014E0DQ38120050-E404B0D1-09D4-4827-B2A5-F3F653910243Q38262225-80AA4502-7122-4B87-8BEF-4F9375F321DFQ38678852-DCB91DB4-7ABD-46F0-A24D-F83FF00E6669Q38746272-2617E6A0-152A-4CA2-BC60-6C6228FACFB9Q38850130-18B61E00-81EC-44ED-9892-87813CC7D631Q47629626-9EE4E96F-EABB-44A7-9851-251D6D115FC6Q47746645-55A52260-8464-4E38-92A5-7821F1436DE0Q47791456-9D67675F-2E3B-4BD4-915F-21316976D74FQ48672351-111047D8-9AB8-44B9-9F98-69E45A3CAC48Q50042086-B6EC9864-DBBA-47D6-B81F-2EBF4ECF6648
P2860
Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@en
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@nl
type
label
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@en
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@nl
prefLabel
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@en
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Ethosuximide reduces epileptog ...... genetic generalized epilepsy.
@en
P2093
Ezgi Ozturk
Gabi Dezsi
Hal Blumenfeld
P2860
P304
P356
10.1111/EPI.12118
P577
2013-03-06T00:00:00Z